172 related articles for article (PubMed ID: 18158738)
21. Evaluation in mice of the immunogenicity and protective efficacy of a tetravalent subunit vaccine candidate against dengue virus.
Lazo L; Izquierdo A; Suzarte E; Gil L; Valdés I; Marcos E; Álvarez M; Romero Y; Guzmán MG; Guillén G; Hermida Cruz L
Microbiol Immunol; 2014 Apr; 58(4):219-26. PubMed ID: 24689365
[TBL] [Abstract][Full Text] [Related]
22. Elaboration of tetravalent antibody responses against dengue viruses using a subunit vaccine comprised of a single consensus dengue envelope sequence.
Sun J; Li M; Wang Y; Hao P; Jin X
Vaccine; 2017 Nov; 35(46):6308-6320. PubMed ID: 28987441
[TBL] [Abstract][Full Text] [Related]
23. Pichia pastoris-expressed dengue virus type 2 envelope domain III elicits virus-neutralizing antibodies.
Batra G; Raut R; Dahiya S; Kamran N; Swaminathan S; Khanna N
J Virol Methods; 2010 Jul; 167(1):10-6. PubMed ID: 20211204
[TBL] [Abstract][Full Text] [Related]
24. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica.
Roehrig JT; Bolin RA; Kelly RG
Virology; 1998 Jul; 246(2):317-28. PubMed ID: 9657950
[TBL] [Abstract][Full Text] [Related]
25. Synthetic B-Cell Epitopes Eliciting Cross-Neutralizing Antibodies: Strategies for Future Dengue Vaccine.
Ramanathan B; Poh CL; Kirk K; McBride WJ; Aaskov J; Grollo L
PLoS One; 2016; 11(5):e0155900. PubMed ID: 27223692
[TBL] [Abstract][Full Text] [Related]
26. Generation and characterization of monoclonal antibodies against dengue virus type 1 for epitope mapping and serological detection by epitope-based peptide antigens.
Chen YC; Huang HN; Lin CT; Chen YF; King CC; Wu HC
Clin Vaccine Immunol; 2007 Apr; 14(4):404-11. PubMed ID: 17287314
[TBL] [Abstract][Full Text] [Related]
27. Novel vaccination approach for dengue infection based on recombinant immune complex universal platform.
Kim MY; Reljic R; Kilbourne J; Ceballos-Olvera I; Yang MS; Reyes-del Valle J; Mason HS
Vaccine; 2015 Apr; 33(15):1830-8. PubMed ID: 25728317
[TBL] [Abstract][Full Text] [Related]
28. Induction of virus-neutralizing antibodies and T cell responses by dengue virus type 1 virus-like particles prepared from Pichia pastoris.
Tang YX; Jiang LF; Zhou JM; Yin Y; Yang XM; Liu WQ; Fang DY
Chin Med J (Engl); 2012 Jun; 125(11):1986-92. PubMed ID: 22884066
[TBL] [Abstract][Full Text] [Related]
29. A vaccine formulation consisting of nucleocapsid-like particles from Dengue-2 and the fusion protein P64k-domain III from Dengue-1 induces a protective immune response against the homologous serotypes in mice.
Lazo L; Gil L; López C; Valdés I; Blanco A; Pavón A; Romero Y; Guzmán MG; Guillén G; Hermida L
Acta Trop; 2012 Nov; 124(2):107-12. PubMed ID: 22750482
[TBL] [Abstract][Full Text] [Related]
30. An adenovirus prime/plasmid boost strategy for induction of equipotent immune responses to two dengue virus serotypes.
Khanam S; Rajendra P; Khanna N; Swaminathan S
BMC Biotechnol; 2007 Feb; 7():10. PubMed ID: 17302980
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of tetravalent and conserved synthetic peptides vaccines derived from Dengue virus Envelope domain I and II.
Rocha RP; Livonesi MC; Fumagalli MJ; Rodrigues NF; da Costa LC; Dos Santos MC; de Oliveira Rocha ES; Kroon EG; Malaquias LC; Coelho LF
Virus Res; 2014 Aug; 188():122-7. PubMed ID: 24768848
[TBL] [Abstract][Full Text] [Related]
32. Tetravalent dengue DIIIC protein together with alum and ODN elicits a Th1 response and neutralizing antibodies in mice.
Zuest R; Valdes I; Skibinski D; Lin Y; Toh YX; Chan K; Hermida L; Connolly J; Guillen G; Fink K
Vaccine; 2015 Mar; 33(12):1474-82. PubMed ID: 25659270
[TBL] [Abstract][Full Text] [Related]
33. Immunogenicity of novel Dengue virus epitopes identified by bioinformatic analysis.
Sánchez-Burgos G; Ramos-Castañeda J; Cedillo-Rivera R; Dumonteil E
Virus Res; 2010 Oct; 153(1):113-20. PubMed ID: 20638434
[TBL] [Abstract][Full Text] [Related]
34. Recombinant, live-attenuated tetravalent dengue virus vaccine formulations induce a balanced, broad, and protective neutralizing antibody response against each of the four serotypes in rhesus monkeys.
Blaney JE; Matro JM; Murphy BR; Whitehead SS
J Virol; 2005 May; 79(9):5516-28. PubMed ID: 15827166
[TBL] [Abstract][Full Text] [Related]
35. Vaccination with dengue virus-like particles induces humoral and cellular immune responses in mice.
Zhang S; Liang M; Gu W; Li C; Miao F; Wang X; Jin C; Zhang L; Zhang F; Zhang Q; Jiang L; Li M; Li D
Virol J; 2011 Jun; 8():333. PubMed ID: 21714940
[TBL] [Abstract][Full Text] [Related]
36. Carboxy-terminally truncated Dengue 4 virus envelope glycoprotein expressed in Pichia pastoris induced neutralizing antibodies and resistance to Dengue 4 virus challenge in mice.
Muné M; Rodríguez R; Ramírez R; Soto Y; Sierra B; Rodríguez Roche R; Marquez G; Garcia J; Guillén G; Guzmán MG
Arch Virol; 2003 Nov; 148(11):2267-73. PubMed ID: 14579183
[TBL] [Abstract][Full Text] [Related]
37. Generation and preclinical evaluation of a DENV-1/2 prM+E chimeric live attenuated vaccine candidate with enhanced prM cleavage.
Keelapang P; Nitatpattana N; Suphatrakul A; Punyahathaikul S; Sriburi R; Pulmanausahakul R; Pichyangkul S; Malasit P; Yoksan S; Sittisombut N
Vaccine; 2013 Oct; 31(44):5134-40. PubMed ID: 23973247
[TBL] [Abstract][Full Text] [Related]
38. Induction of neutralizing antibodies and T cell responses by dengue virus type 2 envelope domain III encoded by plasmid and adenoviral vectors.
Khanam S; Khanna N; Swaminathan S
Vaccine; 2006 Oct; 24(42-43):6513-25. PubMed ID: 16860446
[TBL] [Abstract][Full Text] [Related]
39. Capsid protein: evidences about the partial protective role of neutralizing antibody-independent immunity against dengue in monkeys.
Gil L; Izquierdo A; Lazo L; Valdés I; Ambala P; Ochola L; Marcos E; Suzarte E; Kariuki T; Guzmán G; Guillén G; Hermida L
Virology; 2014 May; 456-457():70-6. PubMed ID: 24889226
[TBL] [Abstract][Full Text] [Related]
40. Viremia and immunogenicity in nonhuman primates of a tetravalent yellow fever-dengue chimeric vaccine: genetic reconstructions, dose adjustment, and antibody responses against wild-type dengue virus isolates.
Guirakhoo F; Pugachev K; Arroyo J; Miller C; Zhang ZX; Weltzin R; Georgakopoulos K; Catalan J; Ocran S; Draper K; Monath TP
Virology; 2002 Jun; 298(1):146-59. PubMed ID: 12093182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]